They have illustrated that ADAM9 was over-expressed in human HCC tissues which resulted in decreased expression of membrane-bound MICA, increased production of soluble MICA and reduction of NK sensitivity of human HCC cells. Here, ADAM9 is linked to hepatocellular carcinoma.